Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Primary hyperaldosteronism (Conn's syndrome) is a common but underdiagnosed cause of high blood pressure. It occurs when the adrenal glands overproduce the hormone aldosterone, causing the body to retain sodium, increase blood volume, and often lose potassium.
Key facts about primary hyperaldosteronism:
Because symptoms like fatigue, muscle cramps, headaches, and stubborn high blood pressure overlap with many other conditions, this disorder is frequently missed for years. Identifying it early can prevent long-term damage to the heart, kidneys, and blood vessels.
If any of this sounds familiar, the smartest next step is clarity. Take a free, instant, online symptom check to see how your symptoms align with primary hyperaldosteronism and related conditions. In just minutes, you'll get personalized insights to help you decide whether to talk with your doctor, request specific lab tests, or simply rule it out — empowering you to navigate next steps with confidence rather than guesswork.
Reviewed for medical accuracy: 06/15/2026
High blood pressure (hypertension) affects millions of people worldwide. While many cases are labeled as "essential" (meaning no identifiable cause), an important subset is due to primary hyperaldosteronism. This condition involves the adrenal glands producing too much aldosterone, a hormone that controls salt and water balance. Although primary hyperaldosteronism is more common than once thought, it often goes unrecognized.
Hyperaldosteronism occurs when the adrenal glands (located above each kidney) make excessive aldosterone. In primary hyperaldosteronism:
Aldosterone is part of the renin–angiotensin–aldosterone system (RAAS):
In primary hyperaldosteronism, aldosterone secretion is excessive and unregulated, so blood pressure stays persistently high.
Primary hyperaldosteronism was once considered rare. Today, studies show it may account for 5–15% of people with high blood pressure, especially in:
Yet many cases slip through the cracks because:
Endocrinology guidelines recommend screening for hyperaldosteronism in people who have:
Many people with primary hyperaldosteronism have no obvious symptoms beyond high blood pressure. When symptoms do appear, they can include:
If you're experiencing these symptoms alongside elevated blood pressure that's difficult to manage, use this free high blood pressure symptom checker to help determine whether hyperaldosteronism might be contributing to your condition.
Screening Tests
Confirmatory Testing
Subtyping
Early diagnosis can make treatment more effective and may reduce the risk of heart disease, stroke, and kidney damage.
With proper treatment:
Untreated hyperaldosteronism can worsen cardiovascular risks over time.
If you have any of the following, speak to a healthcare professional:
Always discuss any test results or symptoms with your doctor. If you experience severe headache, chest pain, sudden weakness, trouble speaking, or vision changes, these could be signs of a life-threatening event—seek emergency care right away.
Primary hyperaldosteronism may not be well known, but it's an important diagnosis to consider in people with persistent or resistant high blood pressure. Early detection and tailored treatment can improve quality of life and reduce long-term health risks. If you think hyperaldosteronism might be behind your hypertension, talk to your healthcare provider for further evaluation. And remember: always seek professional advice for anything that could be life threatening or serious.
(References)
* Young, William F. "Primary Aldosteronism: An Underrecognized and Treatable Cause of Hypertension." *Hypertension* 78, no. 5 (November 2021): e132-e143. doi:10.1161/HYPERTENSIONAHA.121.18222.
* Mulatero, Paolo, Franco Mantero, and Martin Reincke. "Primary Aldosteronism: Current Concepts in Diagnosis and Treatment." *Endocrinology and Metabolism Clinics of North America* 50, no. 1 (March 2021): 27-40. doi:10.1016/j.ecl.2020.10.005.
* Käyser, Bianca D., Iñigo San-Cristobal, Jaume Capdevila, and Alberto M. Palma-Diaz. "Prevalence of primary aldosteronism: a systematic review and meta-analysis." *Lancet Diabetes Endocrinol* 8, no. 6 (June 2020): 510-520. doi:10.1016/S2213-8587(20)30060-4.
* Funder, John W. "Screening for primary aldosteronism: current concepts and future directions." *Curr Opin Nephrol Hypertens* 30, no. 2 (March 2021): 189-194. doi:10.1097/MNH.0000000000000676.
* Anwar, Mohamed, and Michael Stowasser. "Challenges in the diagnosis and management of primary aldosteronism." *Endocrine* 68, no. 3 (June 2020): 483-492. doi:10.1007/s12020-020-02330-y.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.